Report indicates that access via NHS would not only relieve the healthcare system but also generate billions by reintegrating chronic patients into the workforce

Anvisa points out the USA as the main supplier, followed by Canada, Colombia, and Uruguay

In Deusa Cast, experts discuss the possibility of storing cannabis-based products in Brazil. Regulatory advances, legal obstacles, and logistical impacts were debated in light of RDCs 660 and 327

In Deusa Cast, experts discuss the possibility of storing cannabis-based products in Brazil. Regulatory advances, legal hurdles, and logistical impacts were debated in light of RDCs 660 and 327

Published by Anvisa, new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country

Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country

Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country

In one year, the country records an increase of nearly 12,000 qualified doctors and a 50% growth in medical cannabis prescriptions

In Deusa Cast, Marcelo Grecco analyzes the future of cannabis in Brazil and argues that the sector needs to move away from the “same basket” and advance to a phase of focus and specialization

Partnership will allow affiliated unions to offer medical care and therapies with cannabis to members and their families

Parliamentarians, doctors, and associations advocated for greater access to treatments, evaluated the therapeutic potential of THC, and announced a R$ 1.25 million call for research and innovation in the sector.

From Amsterdam's coffeeshops to Brazilian genetic banks, the history of cannabis shows how the Netherlands became a global reference in innovation

Meeting discussed the role of associations in the Cannabis regulation process in Brazil

On Deusa Cast, lawyer Larissa Meneghel details how the five-year deadline set forth in RDC-327 for clinical cannabis research works and comments on the renewal proposal under review by Anvisa

Public hearing will present a balance of the first year of cannabis in the São Paulo SUS and encourage projects in science, innovation, and social impact

According to Clayton Medeiros, access to health should not depend on habeas corpus, but on clear and inclusive public policies

Understand how the substance can influence appetite, anxiety, and mood, and what essential medical care is needed

Organizations are pressuring President Trump to legalize marijuana in the US, going beyond mere rescheduling and seeking to repair the damages of historical prohibition

The oncological pain market is expected to grow from $6.53 billion in 2024 to $11.81 billion by 2034, driven by opioids, non-opioids, and medical cannabis as a promising alternative for pain relief in cancer patients.

Unprecedented partnership aims to combine science, innovation, and regulation to turn hemp into a new frontier of Brazilian agribusiness